Clene Inc.
Data quality: 100%
CLNN
Nasdaq
Manufacturing
Chemicals
$6.29
▼
$0.11
(-1.72%)
Mkt Cap: 74.09 M
Price
$6.29
Mkt Cap
74.09 M
Day Range
$6.15 — $6.44
52-Week Range
$2.28 — $13.50
Volume
55,679
Open $6.38
50D / 200D Avg
$5.02
25.38% above
50D / 200D Avg
$5.98
5.17% above
Quick Summary
Key Takeaways
Revenue declined -27.48% annually over 5 years
Negative free cash flow of -18.59 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 14.04%
Growth
Revenue Growth (5Y)
-27.48%
Below sector avg (1.82%)
Revenue (1Y)-41.52%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-127.72%
Net Margin-13086.50%
Op. Margin-11541.50%
Safety
Debt / Equity
N/A
Current Ratio1.53
Interest Coverage-8.61
Valuation
PE (TTM)
-2.83
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.8 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.5 |
| Net Margin % | -13086.5 | -41.5 |
| Rev Growth 5Y % | -27.5 | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -41.52% | Revenue Growth (3Y) | -44.70% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -27.48% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 200,000.0 | Net Income (TTM) | -26.17 M |
| ROE | N/A | ROA | -117.80% |
| Gross Margin | N/A | Operating Margin | -11541.50% |
| Net Margin | -13086.50% | Free Cash Flow (TTM) | -18.59 M |
| ROIC | -127.72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.53 |
| Interest Coverage | -8.61 | Asset Turnover | 0.01 |
| Working Capital | 4.37 M | Tangible Book Value | -12.36 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.83 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 370.43 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -25.09% | ||
| Market Cap | 74.09 M | Enterprise Value | 84.04 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 0.02 |
| FCF / Share | -1.58 | OCF / Share | -1.57 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 19.50% | FCF Conversion | 71.01% |
| SBC-Adj. FCF | -25.79 M | Growth Momentum | -14.04 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 200,000.0 | 342,000.0 | 654,000.0 | 473,000.0 | 723,000.0 |
| Net Income | -26.17 M | -39.40 M | -49.50 M | -29.92 M | -9.74 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -23.08 M | -33.09 M | -40.54 M | -48.41 M | -49.98 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 14.01 M | 20.06 M | 26.66 M | 31.92 M | 28.42 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 2.68 M | 4.06 M | 4.56 M | -3.30 M | 870,000.0 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | -428,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 18.13 M | 27.34 M | 52.34 M | 44.49 M | 63.06 M |
| Total Liabilities | 35.72 M | 36.19 M | 38.95 M | 41.26 M | 50.47 M |
| Shareholders' Equity | -17.59 M | -8.86 M | 13.39 M | 3.24 M | 12.60 M |
| Total Debt | 17.79 M | — | — | — | — |
| Cash & Equivalents | 5.19 M | 12.16 M | 28.82 M | 18.33 M | 50.35 M |
| Current Assets | 8.98 M | 16.16 M | 38.85 M | 29.20 M | 54.58 M |
| Current Liabilities | 10.78 M | 10.29 M | 25.33 M | 13.86 M | 6.03 M |
{"event":"ticker_viewed","properties":{"ticker":"CLNN","listing_kind":"stock","pathname":"/stocks/clnn","exchange":"Nasdaq","country":"US"}}